Product

Digihaler FB 400 Inhaler

Digihaler FB 400 Inhaler

434 511
- +

Information about Digihaler FB 400 Inhaler

The Digihaler FB 400 is another variant of the inhaler that contains formoterol fumarate, similar to the Digihaler FB 200. Here's some information about the Digihaler FB 400:

  1. Active Ingredient: Formoterol fumarate, a long-acting beta agonist (LABA) medication.

  2. Indications: It is used for the long-term maintenance treatment of asthma in patients aged 12 years and older. It is also used for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

  3. Strength: The Digihaler FB 400 contains a higher dose of formoterol fumarate compared to the Digihaler FB 200. The increased strength may be prescribed based on the severity of the patient's condition and their individual response to treatment.

  4. Mechanism of Action: Like Digihaler FB 200, it works by relaxing the muscles in the airways, thereby helping to improve breathing and reduce symptoms of asthma and COPD.

  5. Digital Inhaler: Similar to Digihaler FB 200, the Digihaler FB 400 features a built-in sensor that records inhalation data. This data can be synchronized with a smartphone app to track medication usage and adherence.

  6. Prescription: It is a prescription medication and should only be used under the guidance of a healthcare provider. Your doctor will determine the appropriate dose and provide instructions on how to use it correctly.

  7. Side Effects: Common side effects may include headache, tremor, throat irritation, or palpitations. As with any medication, serious side effects such as increased blood pressure or heart rate can occur and should be reported to your healthcare provider promptly.

If you have been prescribed Digihaler FB 400 or are considering it, it's essential to follow your healthcare provider's instructions carefully and discuss any questions or concerns you may have about its use and potential side effects.